Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma

Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma

Abstract Background Chemotherapy is one of major therapeutic regimens for neuroblastoma (NB) in children. However, recurrence and metastasis associated with poor prognosis caused by acquired multidrug resistance remains a challenge. There is a great need to achieve new insight into the molecular mec...

ver descrição completa

Detalhes bibliográficos
Principais autores: Yi Wang, Kai Chen, Yihong Cai, Yuanxia Cai, Xiaojun Yuan, Lifeng Wang, Zhixiang Wu, Yeming Wu
Formato: Artigo
Idioma:English
Publicado em: BMC 2017-08-01
coleção:Journal of Experimental & Clinical Cancer Research
Assuntos:
Proteomics
ANXA2
Chemotherapy
Drug resistance
NF-κB
Neuroblastoma
Acesso em linha:http://link.springer.com/article/10.1186/s13046-017-0581-6

Internet

http://link.springer.com/article/10.1186/s13046-017-0581-6

Registros relacionados